Gilead Sciences, Inc.
GILDLast close · Oct 16, 2026156.19−1.18 (−0.75%)
Market cap$193.7B
Of the 85 managers this site tracks, 4 held Gilead Sciences (GILD) at the end of Q2 2026, their latest 13Fs. The largest position by value was Dodge & Cox's, $3.0B; Bridgewater's ($36.7M) and John Rogers's ($24.7M) follow. No Schedule 13D or 13G is on file for GILD from the activists and large holders the site follows.
Superinvestors holding GILD
| Manager | Firm | Quarter | Shares | Value |
|---|---|---|---|---|
| Dodge & Cox | Dodge & Cox | Q2 2026 | 24M | $3.0B |
| Bridgewater | Bridgewater Associates, LP | Q2 2026 | 290,881 | $36.7M |
| John Rogers | Ariel Investments, LLC | Q2 2026 | 195,657 | $24.7M |
| Mairs & Power | Mairs & Power Inc | Q2 2026 | 2,275 | $287,424 |
13D/13G are SEC beneficial-ownership disclosures, triggered only above 5%; a 13F is a quarterly snapshot filed up to 45 days after quarter end. Superinvestor names link to their full portfolios under Investors.